Skandinaviska Enskilda Banken (SEB)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,500
Closed -$183K 939
2023
Q4
$183K Hold
8,500
﹤0.01% 839
2023
Q3
$158K Buy
+8,500
New +$198K ﹤0.01% 848
2022
Q4
Sell
-32,191
Closed -$816K 908
2022
Q3
$816K Sell
32,191
-13,237
-29% -$464K 0.01% 711
2022
Q2
$1.51M Buy
45,428
+15,169
+50% +$644K 0.01% 637
2022
Q1
$2.18M Sell
30,259
-1,076
-3% -$77.5K 0.01% 605
2021
Q4
$2.96M Sell
31,335
-1,165
-4% -$139K 0.02% 553
2021
Q3
$4.12M Sell
32,500
-20,125
-38% -$2.93M 0.02% 460
2021
Q2
$8.75M Sell
52,625
-24,044
-31% -$3.9M 0.05% 308
2021
Q1
$13.9M Buy
76,669
+50,678
+195% +$11.8M 0.09% 214
2020
Q4
$5.2M Buy
25,991
+9,475
+57% +$1.93M 0.04% 368
2020
Q3
$3.62M Buy
16,516
+6,776
+70% +$1.43M 0.03% 406
2020
Q2
$1.86M Buy
+9,740
New +$1.71M 0.02% 584

Other funds holding TDOC

Skandinaviska Enskilda Banken (SEB)'s TDOC Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 8,500 shares — an estimated $183K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in TDOC in Q2 2020 and held it in 12 quarters. The position peaked at $13.9M in Q1 2021. 427 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 8,500 Teladoc Health shares in Q1 2024, an estimated $183K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Teladoc Health in Q2 2020 and held it in 12 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Teladoc Health position peaked at $13.9M in Q1 2021.
  • 427 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.